gloStream, maker of gloEMR and gloPM – the only electronic medical record software and practice management applications with Microsoft® Office built right in – today announced the gloDNA 100% Stimulus Guarantee. Continue Reading

InterMune, Inc. announced today that the U.S. Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. Continue Reading

ISTA Pharmaceuticals, Inc., today announced the Company’s supplemental New Drug Application (sNDA) for once-daily XiDay™ (bromfenac ophthalmic solution) has been accepted for review by the U.S. Food and Drug Administration (FDA). Continue Reading

The University of Texas at San Antonio celebrates the grand opening of its New Venture Incubator, a facility with laboratory, office and meeting spaces to support technology start-ups in the greater San Antonio region. The incubator, housed on UTSA’s Main Campus, will serve as a bridge between San Antonio entrepreneurs and the region’s research and development community. Continue Reading